What happened (WHO dose announcement for DR Congo)
The World Health Organization (WHO) announced that the Democratic Republic of Congo (DR Congo), which is facing an Ebola outbreak, will receive 70,000 doses of Ervebo.
WHO states that Ervebo is approved for protection against Ebola virus disease.
Background (Ebola vaccination within outbreak response)
Ebola virus disease outbreaks require fast public-health action to reduce transmission. Vaccines used in Ebola outbreak control aim to provide protection against Ebola virus disease for people at risk, as part of a wider response that includes surveillance and safe care.
What changed now (named vaccine quantity for DR Congo)
Related current affairs
- Congo receives over 16,000 doses of Ebola vaccine amid health crisis
- Kinsasha: Congo’s Ebola outbreak becomes country’s worst; over 2,300 dead
- WHO says Congo’s Ebola outbreak is on track to surpass the deadliest in history
- Briefly: WHO says Ebola outbreak is 47 dead; worst in region
- WHO says Ebola outbreak starts in DRC, not elsewhere
- Briefly: WHO says Ebola outbreak started in one village in Democratic Republic of Congo